1,900
Participants
Start Date
October 31, 2025
Primary Completion Date
June 30, 2028
Study Completion Date
May 31, 2033
Gentamicin + narrow spectrum betalactam
Empirical therapy for suspected community-acquired sepsis with gentamicin + narrow spectrum betalactam (either one of penicillin, ampicillin, or cloxacillin)
Cefotaxime
Empirical therapy for suspected community-acquired sepsis with cefotaxime
Piperacillin-tazobactam
Empirical therapy for suspected community-acquired sepsis with piperacillin-tazobactam
Akershus University Hospital, Lørenskog
Oslo University Hospital Ullevål, Oslo
Ullevaal University Hospital
OTHER
University Hospital, Akershus
OTHER